
Joel M. Shulman Ph.D., CFA
Dr. Joel Shulman is the CEO and CIO of ERShares. He is the architect of the Entrepreneur Factor® and ERShares’ VC lens investment framework, which applies venture-style research principles to publicly traded companies.
VC-Style* Research for Public Markets: built by a multidisciplinary team focused on identifying companies across public and private markets through our proprietary VC Lens framework.
Built on 30+ years of research from Babson College & Harvard University.
VC Lens methodology applied with institutional rigor across every allocation decision within public markets.
Operating standards built for advisors, allocators, and individual investors alike.
Each member brings a distinct lens to private and public market investing, drawn from research, capital markets, and operating roles.

Dr. Joel Shulman is the CEO and CIO of ERShares. He is the architect of the Entrepreneur Factor® and ERShares’ VC lens investment framework, which applies venture-style research principles to publicly traded companies.

Eva Ados is Chief Investment Strategist and Chief Operating Officer at ERShares, where she helps shape the firm’s macro views, thematic research priorities, and operations.

Kevin Cramton is Director of Private Equity at ERShares, where he focuses on private-market research, evaluation, and due diligence related to private-company exposure.

Mihai Prisacariu is Senior Vice President of Operations and Compliance at ERShares. He supports compliance policies, risk management, regulatory oversight, ETF market research, investment structuring, and operational processes. He has been involved with ERShares’ regulatory and operational functions since 2017.

Rahul Raj is a Senior Financial Analyst at ERShares, focused on portfolio management support, financial analysis, and research across ETFs, mutual funds, and index strategies.
Original analysis and fund updates from the ERShares team. Or reach out directly to discuss XOVR, ENTIX, or how the VC Lens methodology applies to your portfolio.
ERShares funds are available through most major brokerage platforms. Buy XOVR and ENTIX directly in your existing account.
Important notice for Fidelity investors
Fidelity applies a transaction-based service fee of up to $100 on purchases of XOVR. This fee is determined and collected solely by Fidelity. It is not charged by XOVR or ERShares and does not benefit the fund. XOVR may be available through other brokerage platforms without this fee. Please review your brokerage firm’s current fee schedule before investing. Brokerage fees and availability are subject to change.
We are continuously working on increasing the availability of ERShares products on all platforms. If you do not see the funds or platforms you are interested in on this list, please reach out through the Contact Us page and we will make it a priority to have the funds you are interested in on the platform you want to invest on. Note: The ERShares ETF and Mutual Funds are listed on the Nasdaq Exchange. Thus, all platforms that can access Nasdaq listed stocks, products, ETFs, or Mutual Funds should be able to access the ERShares ETF and Mutual Funds.
Subscribe to our newsletter to stay updated about the global markets.
Original analysis and fund updates. Delivered to your inbox. No spam, unsubscribe anytime.
By subscribing you agree to receive emails from ERShares. See our Privacy Policy.